Rheumatoid Arthritis

Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate
NCT01373151 | PHASE 2 | INTERVENTIONAL

The purpose of this study is to determine the effective dose of BMS-945429 in subjects with inadequate response to Methotrexate in the treatment of moderate to severe Rheumatoid Arthritis.

Trial Information
100 Sites
418 Participants
Recruiting
18 Years to 55 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

SUBMIT
Sun Valley Arthritis Center, Ltd.
Peoria,Arizona,United States,85381
San Diego Arthritis Medical Clinic
San Diego,California,United States,92108
New England Research Associates, Llc
Trumbull,Connecticut,United States,06611
Quincy Medical Group
Quincy,Illinois,United States,62301
Rockford Orthopedic Associates, Llc.
Rockford,Illinois,United States,61107
Clinical Pharmacology Study Group
Worcester,Massachusetts,United States,01605
Arthritis Associates Of Mississippi
Jackson,Mississippi,United States,39202
Physician Research Collaboration, Llc
Lincoln,Nebraska,United States,68516
Box Arthritis And Rheumatology Of The Carolinas, Pllc
Charlotte,North Carolina,United States,28210
Health Research Of Oklahoma
Oklahoma City,Oklahoma,United States,73103
East Penn Rheumatology Associates, P.C.
Bethlehem,Pennsylvania,United States,18015
Altoona Center For Clinical Research
Duncansville,Pennsylvania,United States,16635
Seattle Rheumatology Associates
Seattle,Washington,United States,98104
Local Institution
Capital Federal,Buenos Aires,Argentina,1015
Local Institution
Capital Federal,Buenos Aires,Argentina,1425
Local Institution
Capital Federal,Buenos Aires,Argentina,1428
Local Institution
Capital Federal,Buenos Aires,Argentina,1431
Local Institution
Rosario,Santa FE,Argentina,2000
Local Institution
San Miguel De Tucuman,Tucuman,Argentina,4000
Local Institution
Cordoba,Argentina,5000
Local Institution
San Juan,Argentina,5400
Local Institution
Bruxelles,Belgium,1200
Local Institution
Hasselt,Belgium,3500
Local Institution
Goiania,Goias,Brazil,74110
Local Institution
Juiz De Fora,Minas Gerais,Brazil,36010
Local Institution
Curitiba,Parana,Brazil,80060
Local Institution
Curitiba,Parana,Brazil,80440
Local Institution
Porto Alegre,Rio Grande Do Sul,Brazil,91610
Local Institution
Sao Paulo,Brazil,04032
Local Institution
Sao Paulo,Brazil,04266
Local Institution
Montreal,Quebec,Canada,H2L1S6
Centre De Recherche MusculoSquelettique
Trois-rivieres,Quebec,Canada,G8Z1Y2
Local Institution
Quebec,Canada,G1W4R4
Local Institution
Praha 2,Czechia,12850
Local Institution
Praha 4,Czechia,14059
Local Institution
Bordeaux Cedex,France,33076
Local Institution
Chambray Les Tours,France,37170
Local Institution
Strasbourg Cedex,France,67098
Local Institution
Berlin,Germany,14059
Local Institution
Koeln,Germany,50931
Local Institution
Leipzig,Germany,04103
Local Institution
Wuerzburg,Germany,97080
Local Institution
Budapest,Hungary,1027
Local Institution
Debrecen,Hungary,4012
Local Institution
Gyula,Hungary,5700
Local Institution
Veszprem,Hungary,8200
Local Institution
Napoli,Italy,80131
Local Institution
Padova,Italy,35128
Local Institution
Reggio Emilia,Italy,42100
Local Institution
Chiba-shi,Chiba,Japan,2608712
Local Institution
Kitakyushu-shi,Fukuoka,Japan,8078555
Local Institution
Higashi-hiroshima-shi,Hiroshima,Japan,7390002
Local Institution
Kato-shi,Hyogo,Japan,6731462
Local Institution
Miyazaki-shi,Miyazaki,Japan,8800122
Local Institution
Nagano-shi,Nagano,Japan,3808582
Local Institution
Nagasaki-shi,Nagasaki,Japan,8528501
Local Institution
Sasebo-shi,Nagasaki,Japan,8571195
Local Institution
Tomigusuku-shi,Okinawa,Japan,9010243
Local Institution
Osaka-shi,Osaka,Japan,5458586
Local Institution
Shizuoka-shi,Shizuoka,Japan,4208623
Local Institution
Bunkyo-ku,Tokyo,Japan,1138519
Local Institution
Shinjuku-Ku,Tokyo,Japan,1608582
Local Institution
Toshima-ku,Tokyo,Japan,1708476
Local Institution
Daegu,Korea, Republic of,705-718
Local Institution
Seoul,Korea, Republic of,133-792
Local Institution
Seoul,Korea, Republic of,137-701
Local Institution
Mexico City,Distrito Federal,Mexico,11850
Local Institution
Guadalajara,Jalisco,Mexico,42650
Local Institution
Guadalajara,Jalisco,Mexico,45040
Local Institution
Morelia,Michioacan,Mexico,58270
Local Institution
Monterrey,Nuevo Leon,Mexico,64020
Local Institution
Culiacan,Sinaloa,Mexico,80230
Local Institution
San Luis Potosi,Mexico,78213
Local Institution
Amsterdam,Netherlands,1056AB
Local Institution
Katowice,Poland,40-748
Local Institution
Krakow,Poland,31-531
Local Institution
Poznan,Poland,60773
Local Institution
Warszawa,Poland,01-868
Local Institution
Warszawa,Poland,02-118
Local Institution
Ekaterinburg,Russian Federation,620102
Local Institution
Kazan,Russian Federation,420064
Local Institution
Moscow,Russian Federation,115522
Local Institution
Novosibirsk,Russian Federation,630005
Local Institution
St. Petersburg,Russian Federation,191014
Local Institution
Yaroslavl,Russian Federation,150003
Local Institution
Pretoria,Gauteng,South Africa,0083
Local Institution
Pretoria,Gauteng,South Africa,0132
Local Institution
Durban,KWA ZULU Natal,South Africa,4001
Local Institution
Panorama,Western CAPE,South Africa,7500
Local Institution
Pinelands, Cape Town,Western Cape,South Africa,7405
Local Institution
Tygerberg,Western CAPE,South Africa,7505
Local Institution
A Coruna,Spain,15006
Local Institution
Madrid,Spain,28040
Local Institution
Santander,Spain,39008
Local Institution
Santiago De Compostela,Spain,15706
Local Institution
Sevilla,Spain,41071
Local Institution
Changhua,Taiwan,500
Local Institution
Kaohsiung,Taiwan,833
Local Institution
Taichung,Taiwan,404
Local Institution
Taoyuan,Taiwan,333

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov